Skip to main content
. 2020 Jan 30;13(2):22. doi: 10.3390/ph13020022

Table 2.

Summary of chelators for the different radioactive isotopes and published labelling conditions (reaction temperature and incubation time).

Isotope Chelator Labelling Conditions Reference
[64Cu] CB-TE2A a 95 °C, 1 h [113]
CB-TE2P RT [80]
DOTA b RT, 15 min [114]
NOTA c RT, 45 min [115]
PCB-TE2A RT [75]
TETA d RT, 45 min [74]
Sarcophagine-based chelators RT, within min [75,82]
[68Ga] AAZTA e RT, 10 min [116]
DFO f RT, 5 min [116]
DOTA b 95 °C, 5 min [116]
DTPA g RT, 10 min [117]
HBED-CC h 80–100 °C, 5–20 min [85]
NODAGA i RT, 10 min [86]
NOTA c RT, 10 min [118]
TRAPj/NOPO k 95–100 °C, 5 min; RT or 95 °C, 5 min [87,89]
[89Zr] DFO f RT, 30 min [119]
DOTA b 95 °C, 60 min [97]
FSC l RT, 90 min [120]
[90Y] 3p-C-NETA-NCS m RT, 60 min [106]
CHX-A’’-DTPA n 37–75 °C, 30–60 min [82]
DOTA b 80 °C, 20 min [121]
[177Lu] 3p-C-NETA-NCS m RT, 60 min [106]
AAZTA-5 RT, 10 min [104]
DOTA b 80 °C, 20 min [121]
H4octapa o RT, 15 min [105]
[224Ac] DOTA b 95 °C, 5 min [109]
H2macropa p RT, within several min [112]
HEHA q 37 °C, 30 min [122]

a 4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane, b 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, c 1,4,7-triazacyclononane-1,4,7-triacetic acid, d 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid, e 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)]amino-6-methylperhydro-1,4-diazepine, f desferrioxamine B, g diethylenetriamine pentaacetic acid, h N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N′-diacetic acid, i 1,4,7-triazacyclononane,1-gluteric acid-4,7-acetic acid, j 1,4,7-triazacyclononane phosphinic acid, k 1,4,7-triazacyclononane-1,4-bis[methylene(hydroxymethyl)phosphinic acid]-7-[methylene(2-carboxyethyl) phosphinic acid], l fusarinine C, m {4-[2-(Bis-carboxy-methylamino)-5-(4-isothiocyanatophenyl) pentyl]-7-carboxymethyl[1,4,7] triazonan-1-yl}acetic acid, n 2-(p-isothiocyanatobenzyl)-cyclohexyldiethylenetriamine pentaacetic acid, o N,N′-bis(6-carboxy-2-pyridylmethyl)-ethylenediamine-N,N′-diacetic acid), p N,N’-bis[(6-carboxy-2-pyridil)methyl]-4,13-diaza-18-crown-6, q 1,4,7,10,13,16-hexaazacyclohexadecane-N,N′,N″,N,N,N-hexaacetic acid.